Ocular Complications from Chemotherapeutic Agents -CEW

Selumetinib, Binimetinib, Trametinib, Cobimetinib
- Blurred vision, diplopia, eyelid edema, subconjunctival hemorrhage, increased lacrimation
- Retinal pigment epithelial detachment, Central serous-like retinopathy

Ocular toxicities of MEK inhibitors and other targeted therapies. Stjepanovic et al. Annals of Oncology.Volume 27, Issue 6, June 2016, Pages 998-1005
Clinical and Morphological Characteristics of MEK Inhibitor-Associated Retinopathy. Francis, Jasmine H. et al. Ophthalmology. 2017-12, Vol.124 (12), p.1788-1798